BERNARDO, MARIA ESTER
 Distribuzione geografica
Continente #
AS - Asia 3.838
EU - Europa 3.537
NA - Nord America 2.843
SA - Sud America 991
Continente sconosciuto - Info sul continente non disponibili 215
AF - Africa 82
OC - Oceania 10
Totale 11.516
Nazione #
US - Stati Uniti d'America 2.680
RU - Federazione Russa 1.988
SG - Singapore 1.444
CN - Cina 1.180
BR - Brasile 817
SE - Svezia 468
HK - Hong Kong 457
IT - Italia 415
VN - Vietnam 359
FR - Francia 176
DE - Germania 128
BD - Bangladesh 107
GB - Regno Unito 89
CA - Canada 77
AR - Argentina 74
IN - India 63
FI - Finlandia 58
NL - Olanda 58
ID - Indonesia 43
AT - Austria 42
MX - Messico 39
PL - Polonia 34
EC - Ecuador 31
IQ - Iraq 27
ZA - Sudafrica 26
JP - Giappone 22
TR - Turchia 20
UA - Ucraina 18
CR - Costa Rica 17
VE - Venezuela 17
CO - Colombia 16
SA - Arabia Saudita 16
MY - Malesia 15
ES - Italia 14
UZ - Uzbekistan 14
LT - Lituania 13
MA - Marocco 12
EG - Egitto 11
KE - Kenya 11
NP - Nepal 11
PY - Paraguay 11
IL - Israele 9
JM - Giamaica 8
AE - Emirati Arabi Uniti 7
AZ - Azerbaigian 7
CL - Cile 7
DO - Repubblica Dominicana 7
IE - Irlanda 7
MD - Moldavia 7
PE - Perù 7
UY - Uruguay 7
JO - Giordania 6
PK - Pakistan 6
DZ - Algeria 5
IR - Iran 5
AU - Australia 4
CZ - Repubblica Ceca 4
EU - Europa 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
BE - Belgio 3
BO - Bolivia 3
GT - Guatemala 3
LB - Libano 3
NZ - Nuova Zelanda 3
PH - Filippine 3
SV - El Salvador 3
BA - Bosnia-Erzegovina 2
CI - Costa d'Avorio 2
CY - Cipro 2
ET - Etiopia 2
GR - Grecia 2
HN - Honduras 2
KR - Corea 2
MT - Malta 2
NG - Nigeria 2
PT - Portogallo 2
SN - Senegal 2
AM - Armenia 1
AO - Angola 1
BG - Bulgaria 1
BH - Bahrain 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
EE - Estonia 1
FJ - Figi 1
GA - Gabon 1
GE - Georgia 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LV - Lettonia 1
MK - Macedonia 1
MN - Mongolia 1
NA - Namibia 1
NI - Nicaragua 1
NR - Nauru 1
PA - Panama 1
PR - Porto Rico 1
Totale 11.298
Città #
Singapore 547
Moscow 475
Hong Kong 457
Dallas 350
Ashburn 310
San Jose 284
Shanghai 242
Council Bluffs 185
Beijing 163
Hefei 161
Lauterbourg 139
Lawrence 138
Princeton 138
Ho Chi Minh City 126
New York 124
Milan 121
Santa Clara 82
Hanoi 80
Los Angeles 80
São Paulo 66
Helsinki 37
Boardman 33
Rome 33
Nuremberg 29
Orem 29
Montreal 27
Dronten 26
Rio de Janeiro 25
Warsaw 24
London 23
Guangzhou 22
Haiphong 22
Chicago 21
Munich 21
Frankfurt am Main 20
Brooklyn 19
Chennai 19
Houston 19
Curitiba 18
Toronto 17
Johannesburg 16
Phoenix 16
San Francisco 16
Tokyo 16
Atlanta 14
Boston 14
Brasília 14
Da Nang 14
Denver 14
Mexico City 14
Shenzhen 14
Tashkent 14
Guarulhos 13
Poplar 13
Turku 13
Vienna 13
Brescia 12
Cesano Boscone 12
Guayaquil 12
Las Vegas 12
Seattle 12
Stockholm 12
Hangzhou 11
Hải Dương 11
Porto Alegre 11
San José 11
Belo Horizonte 10
Columbus 10
Monza 10
Mumbai 10
Nairobi 10
Salvador 10
Turin 10
Buffalo 9
Kuala Lumpur 9
San Diego 9
Baghdad 8
Lappeenranta 8
Manchester 8
Memphis 8
Naples 8
Philadelphia 8
Recife 8
The Dalles 8
Washington 8
Ankara 7
Boydton 7
Cumming 7
Dhaka 7
Ipatinga 7
Quito 7
Reston 7
Sorocaba 7
Tianjin 7
Amman 6
Cairo 6
Campinas 6
Charlotte 6
Fortaleza 6
Fremont 6
Totale 5.364
Nome #
Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded access 250
Rapamycin-Based GvHD Prophylaxis Is Effective in T-Cell Replete Unmanipulated Haploidentical Peripheral Stem Cell Transplantation for Advanced Haematological Malignancies: Results in 46 Patients 216
A Novel Assay in Whole Blood Demonstrates Restoration of Mitochondrial Activity in Phagocytes After Successful HSCT in Hyperinflamed X-Linked Chronic Granulomatous Disease 161
Case Report: Consistent disease manifestations with a staggered time course in two identical twins affected by adenosine deaminase 2 deficiency 160
Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease 143
Bone marrow harvesting from paediatric patients undergoing haematopoietic stem cell gene therapy 143
Hematopoietic stem-and progenitor-cell gene therapy for hurler syndrome 141
A GLB1 transgene with enhanced therapeutic potential for the preclinical development of ex-vivo gene therapy to treat mucopolysaccharidosis type IVB 134
Early skeletal outcomes after hematopoietic stem and progenitor cell gene therapy for Hurler syndrome 132
Ex Vivo and In Vivo Gene Therapy for Mucopolysaccharidoses: State of the Art 128
Peripheral blood stem and progenitor cell collection in pediatric candidates for ex vivo gene therapy: a 10-year series 126
An innovative platform approach for the development of ex-vivo gene therapies for the treatment of lysosomal storage diseases with skeletal involvement 126
Access to gene therapy for rare diseases when commercialization is not fit for purpose 123
Long-term and real-world safety and efficacy of retroviral gene therapy for adenosine deaminase deficiency 122
Bone marrow stromal cells from β-thalassemia patients have impaired hematopoietic supportive capacity 117
Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study 116
Wiskott–Aldrich syndrome: Oral findings and microbiota in children and review of the literature 113
An early-senescence state in aged mesenchymal stromal cells contributes to hematopoietic stem and progenitor cell clonogenic impairment through the activation of a pro-inflammatory program 111
Assessment of human herpesvirus-6 infection in mesenchymal stromal cells ex vivo expanded for clinical use 110
Familial platelet disorder with propensity to acute myelogenous leukemia: Genetic heterogeneity and progression to leukemia via acquisition of clonal chromosome anomalies 109
Long-Term Effects of Atidarsagene Autotemcel for Metachromatic Leukodystrophy 109
Up to 10.5 Years of Follow-Up in 17 Subjects Treated with Hematopoietic Stem and Progenitor Cell Lentiviral Gene Therapy for Wiskott-Aldrich Syndrome 107
Pioglitazone as a novel therapeutic approach in chronic granulomatous disease 105
A new enzyme-linked immunosorbent assay for a total anti-T lymphocyte globulin determination: Development, analytical validation, and clinical applications 102
Optimization of in vitro expansion of human multipotent mesenchymal stromal cells for cell-therapy approaches: Further insights in the search for a fatal calf serum substitute 100
Biological and functional characterization of bone marrow-derived mesenchymal stromal cells from patients affected by primary immunodeficiency 99
Bone Marrow-Derived Mesenchymal Stromal Cell Intra-Fistular Injections Induce An Up-Regulation Of Foxp3+ Regulatory T-Cells In Patients With Crohn’s Disease 97
Allogeneic hematopoietic stem cell transplantation in thalassemia major: Results of a reduced-toxicity conditioning regimen based on the use of treosulfan 97
Mild SARS-CoV-2 Infection After Gene Therapy in a Child With Wiskott-Aldrich Syndrome: A Case Report 96
Adult autoimmune enteropathy treated with autologous bone marrow-derived mesenchymal stromal cells 94
Biological, functional and genetic characterization of bone marrow-derived mesenchymal stromal cells from pediatric patients affected by acute lymphoblastic leukemia 93
Haematopoietic stem cell gene therapy in inborn errors of metabolism 91
Allogeneic hematopoietic stem cell transplantation may restore gluten tolerance in patients with celiac disease 90
Evidence of Treatment Benefits in Patients with Mucopolysaccharidosis Type I-Hurler in Long-term Follow-up Using a New Magnetic Resonance Imaging Scoring System 90
Bone marrow-derived mesenchymal stromal cells (MSC) locally injected for refractory fistulizing Crohn’s disease modulate immunoglobulin production 89
A low thymic function is associated with leukemia relapse in children given T-cell-depleted HLA-haploidentical stem cell transplantation 89
Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: Evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity 88
Chromosome anomalies in bone marrow as primary cause of aplastic or hypoplastic conditions and peripheral cytopenia: Disorders due to secondary impairment of RUNX1 and MPL genes 88
Autologous bone marrow-derived mesenchymal stem cell infusion in crohn's disease patients with fistulas 87
Emapalumab treatment in an ADA-SCID patient with refractory hemophagocytic lymphohistiocytosis-related graft failure and disseminated BCGitis 87
Preemptive therapy of EBV-related lymphoproliferative disease after pediatric haploidentical stem cell transplantation 85
The EHA Research Roadmap: Hematopoietic Stem Cell Gene Therapy 84
Mesenchymal stromal cells improve the transplantation outcome of CRISPR-Cas9 gene-edited human HSPCs. 83
Cannabinoid receptor 2 as antiobesity target: Inflammation, fat storage, and browning modulation 83
Hematopoietic stem cell transplantation for Wiskott-Aldrich syndrome: an EBMT Inborn Errors Working Party analysis. 79
Cord blood transplantation in childhood 78
Mesenchymal stromal cells: A novel treatment modality for tissue repair 78
The cannabinoid receptor type 2 as mediator of mesenchymal stromal cell immunosuppressive properties 77
Role of ex vivo Expanded Mesenchymal Stromal Cells in Determining Hematopoietic Stem Cell Transplantation Outcome 76
Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent ß-thalassemia 74
Familial myelodysplastic syndromes, monosomy 7/trisomy 8, and mutator effects 74
Inhibition of B-cell proliferation and antibody production by mesenchymal stromal cells is mediated by T cells 74
Hematopoietic Stem Cell Transplantation for Mucopolysaccharidoses: Past, Present, and Future 73
The human leucocyte antigen-G 14-basepair polymorphism correlates with graft-versus-host disease in unrelated bone marrow transplantation for thalassaemia 70
Safety and efficacy of mesenchymal stromal cell therapy in autoimmune disorders 69
In-vivo T-regs generation by rapamycin-mycophenolate-ATG as a new platform for GvHD prophylaxis in T-cell repleted unmanipulated haploidentical peripheral stem cell transplantation: results in 59 patients 68
Resistance to neoplastic transformation of ex-vivo expanded human mesenchymal stromal cells after exposure to supramaximal physical and chemical stress 68
Strategies to optimize the outcome of children given T-cell depleted HLA-haploidentical hematopoietic stem cell transplantation 67
The Role of Conditioning in Hematopoietic Stem-Cell Gene Therapy 67
Ex vivo expansion of mesenchymal stromal cells 67
Mesenchymal Stromal Cells: Role in the BM Niche and in the Support of Hematopoietic Stem Cell Transplantation 66
Treosulfan-based conditioning regimen for allogeneic haematopoietic stem cell transplantation in patients with thalassaemia major 66
MSCs in Pediatric Hematopoietic Stem Cell Transplantation (Chapter 26) 65
The outcome of children with Fanconi anemia given hematopoietic stem cell transplantation and the influence of fludarabine in the conditioning regimen: a report from the Italian pediatric group 65
Efficacy of two different doses of rabbit anti-T-lymphocyte globulin to prevent graft-versus-host disease in children with haematological malignancies transplanted from an unrelated donor: a multicentre, randomised, open-label, phase 3 trial 65
Generation of mesenchymal stromal cells in the presence of platelet lysate: A phenotypic and functional comparison of umbilical cord blood- and bone marrow-derived progenitors 65
Current and Future Perspective in Hematopoietic Stem Progenitor Cell-gene Therapy for Inborn Errors of Metabolism 64
How I treat relapsed childhood acute lymphoblastic leukemia 64
Tailoring cells for clinical needs: Meeting report from the Advanced Therapy in Healthcare symposium (October 28-29 2017, Doha, Qatar) 63
Bone marrow-derived mesenchymal stromal cells locally injected for refractory fistulizing Crohn’s disease modulate serum immunoglobulins, secretory IgA, and antibody production 63
Effects Of Bone Marrow-Derived Mesenchymal Stromal Cells Infused In Fistulas Of Patients With Perianal Crohn’s Disease On Serum Cytokine Pattern, Salivary Iga Production, And Circulating Lymphocyte Subsets 63
Clofarabine, cyclophosphamide and etoposide as single-course re-induction therapy for children with refractory/multiple relapsed acute lymphoblastic leukaemia 63
γδ T-cell reconstitution after HLA-haploidentical hematopoietic transplantation depleted of TCR-αβ+/CD19+ lymphocytes 63
Current practices for nutritional evaluation and care during the treatment of pediatric oncology patients: a survey among AIEOP centers 62
Mesenchymal stromal cells and chronic inflammatory bowel disease 62
Cord blood transplantation in children with haematological malignancies 61
Imbalanced TGFβ signalling and autophagy drive erythroid priming of hematopoietic stem cells in β-thalassemia 61
Human bone marrow-derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms 60
Neonatal gene therapy effectively prevents disease manifestations in a murine model of Mucopolysaccharidosis type I 59
Multiparametric Whole Blood Dissection: A one-shot comprehensive picture of the human hematopoietic system 59
Donor multipotent mesenchymal stromal cells may engraft in pediatric patients given either cord blood or bone marrow transplantation 59
Bone Marrow-Derived Mesenchymal Stromal Cells Locally Injected Induce An Up-Regulation Of Both Circulating And Mucosal Foxp3+ Regulatory T-Cells In Patients With Perianal Crohn’s Disease 58
Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study 58
Gene therapy for mucopolysaccharidoses: In vivo and ex vivo approaches 10 Technology 1004 Medical Biotechnology 58
Transgenic expression of IL-10 by lentiviral vectors for increasing the anti-inflammatory efficacy of mesenchymal stromal cells 57
Successful treatment of fistulizing crohn's disease with local infusions of autologous bone marrow-derived mesenchymal stem cells 57
Low percentages of circulating CD8+/CD45RA+ human T lymphocytes expressing β7 integrin correlate with the occurrence of intestinal acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation 57
Mesenchymal stromal cells: a novel and effective strategy for facilitating engraftment and accelerating hematopoietic recovery after transplantation? 57
Manufacturing Mesenchymal Stromal Cells for the Treatment of Graft-versus-Host Disease: A Survey among Centers Affiliated with the European Society for Blood and Marrow Transplantation 57
Co-transplantation of ex-vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem cell transplantation 57
Successful Treatment With Ledipasvir/Sofosbuvir in an Infant With Severe Combined Immunodeficiency Caused by Adenosine Deaminase Deficiency With HCV Allowed Gene Therapy with Strimvelis 57
Human mesenchymal stem cells derived from bone marrow display a better chondrogenic differentiation compared with other sources 56
Bone osteoblastic and mesenchymal stromal cells lack primarily tumoral features in multiple myeloma patients 55
Mesenchymal stromal cell therapy: a revolution in Regenerative Medicine? 55
Lentiviral gene therapy corrects platelet phenotype and function in Wiskott-Aldrich patients 54
Immunomodulatory properties of MSCs (Chapter 7) 54
Haematopoietic stem cell transplantation for patients with Thalassemia 53
Gene therapy for lysosomal storage disorders: recent advances for metachromatic leukodystrophy and mucopolysaccaridosis I 53
Neonatal umbilical cord blood transplantation halts skeletal disease progression in the murine model of MPS-I 53
MPSI Manifestations and Treatment Outcome: Skeletal Focus 52
Totale 8.549
Categoria #
all - tutte 71.691
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.691


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202285 0 0 0 43 4 7 4 3 15 1 4 4
2022/2023866 313 147 47 4 31 124 13 31 97 6 36 17
2023/2024435 20 23 30 47 36 45 84 32 3 12 31 72
2024/20252.409 317 48 99 36 67 154 253 209 449 325 228 224
2025/20267.033 472 583 479 1.072 491 198 571 489 1.801 348 239 290
2026/2027582 236 346 0 0 0 0 0 0 0 0 0 0
Totale 11.516